These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37209238)

  • 1. Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?
    Naguib H; Abouelnaga SF; Elsayed MM
    Int Urol Nephrol; 2024 Jan; 56(1):217-222. PubMed ID: 37209238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
    Mashaal AR; Abd El-Hameed M; El Ray AA; Mahmoud Diab T; Dawood RM; Shemis MA; Seyam M
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):2965-2971. PubMed ID: 36172658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
    Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
    Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.
    Wang Y; Rao H; Chi X; Li B; Liu H; Wu L; Zhang H; Liu S; Zhou G; Li N; Niu J; Wei L; Zhao J
    EBioMedicine; 2019 Aug; 46():227-235. PubMed ID: 31345785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection.
    Silva E; Marques S; Leal B; Canhão B; Madaleno J; Simão A; Carvalho A
    Virus Res; 2023 May; 329():199104. PubMed ID: 37003528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis C virus infection among haemodialysis patients.
    Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
    Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt.
    Serwah MA; Omar SA; Khedr MS; Abdel-Hamid AES
    Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):1009-1014. PubMed ID: 33731578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.
    Abdelmoemen G; Khodeir SA; Abou-Saif S; Kobtan A; Abd-Elsalam S
    Environ Sci Pollut Res Int; 2018 Feb; 25(6):5459-5464. PubMed ID: 29214477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals.
    Kamhawy A; Ahmed Said ZN; Abdelhamid SE; El-Sayed M; Eletreby R; Garem HE; El Kassas M; Esmat G
    Arab J Gastroenterol; 2021 Jun; 22(2):158-163. PubMed ID: 33820724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
    Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
    Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.
    Khattab MA; Zakaria Y; Sadek E; Abd El Fatah AS; Fouad M; Khattab M; Moness HM; Adel NM; Ahmed E
    Clin Exp Med; 2023 Feb; 23(1):131-140. PubMed ID: 35066710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-viral therapy for occult hepatitis C virus infection.
    Pardo M; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Perez-Mota A; Carreño V
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1153-9. PubMed ID: 16611276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.
    Köse Ş; Senger SS; Ersan G; Çavdar G
    Clin Exp Nephrol; 2013 Feb; 17(1):115-9. PubMed ID: 22814955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
    Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.
    Hanafy AS; Seleem WM; Basha MAA; Marei AM
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1275-1282. PubMed ID: 31149912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
    Alsaran K; Sabry A; Shaheen N
    Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.
    Inglot M; Pawlowski T; Szymczak A; Malyszczak K; Zalewska M; Radkowski M
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():186-91. PubMed ID: 23619217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.